Status:
UNKNOWN
Clinical Research on Advanced Warning Factors Of Respiratory Injury in Dermatomyositis
Lead Sponsor:
The First Affiliated Hospital with Nanjing Medical University
Collaborating Sponsors:
National Natural Science Foundation of China
Conditions:
Dermatomyositis
Respiratory Injury
Eligibility:
All Genders
18+ years
Brief Summary
Dermatomyositis (DM) is a highly heterogeneous autoimmune disease characterized by rash and myasthenia. Beside these, respiratory involvement is one of the common complications of DM. Interstitial lun...
Detailed Description
Dermatomyositis (DM) is a highly heterogeneous autoimmune disease characterized by rash and myasthenia. Beside these, respiratory involvement is one of the common complications of DM. Interstitial lun...
Eligibility Criteria
Inclusion
- adult patients meet the diagnostic criteria for dermatomyositis of Bohan and Peter
Exclusion
- complicated with other connective tissue diseases
- complicated with cardiovascular and respiratory disease caused by other reasons
- interstitial lung disease caused by environment and drugs
- patients with key research missing data or without informed consent
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04747652
Start Date
June 1 2020
End Date
December 31 2022
Last Update
July 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital with Nanjing Medical University
Nanjing, Jiangsu, China, 210029